MicroRNA as a novel drug target for cancer therapy

Bibliography

• Cho WC. MicroRNAs in cancer - from research to therapy. Biochim Biophys Acta 2010;1805:209-17
   PubMed Web of Science ®Google Scholar
• Davidson BL, McCray PB Jr. Current prospects for RNA interference-based therapies. Nat Rev Genet 2011;12(5):329-40
   PubMed Web of Science ®Google Scholar
• Bhattacharyya SN, Habermacher R, Martine U, Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006;125:1111-24
   PubMed Web of Science ®Google Scholar
• Zhao Y, Ransom JF, Li A, Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007;129:303-17
   PubMed Web of Science ®Google Scholar
• Liu N, Bezprozvannaya S, Williams AH, microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 2008;22:3242-54
   PubMed Web of Science ®Google Scholar
• Latronico MVG, Condorelli G. MicroRNAs and cardiac pathology. Nat Rev Cardiol 2009;6:418-29
   Web of Science ®Google Scholar
• Lanford RE, Lanford RE, Hildebrandt-Eriksen ES, Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010;327:198-201
   PubMed Web of Science ®Google Scholar
• Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009;10:704-14
   PubMed Web of Science ®Google Scholar
• Ferracin M, Veronese A, Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn 2010;10:297-308
   PubMed Web of Science ®Google Scholar
• Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 2010;42:1273-81
   PubMed Web of Science ®Google Scholar
• Foekens JA, Sieuwerts AM, Smid M, Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci USA 2008;105:13021-6
   PubMed Web of Science ®Google Scholar
• Tavazoie SF, Alarcon C, Oskarsson T, Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008;451:147-52
   PubMed Web of Science ®Google Scholar
• Zhang L, Sullivan PS, Goodman JC, MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase. Cancer Res 2011;71:645-54
   PubMed Web of Science ®Google Scholar
• Zhang X, Yu H, Lou JR, MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells. J Biol Chem 2011;286:1429-35
   Google Scholar
• Asaga S, Kuo C, Nguyen T, Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem 2011;57:84-91
   PubMed Web of Science ®Google Scholar
• Arisawa T, Tahara T, Shibata T, A polymorphism of microRNA 27a genome region is associated with the development of gastric mucosal atrophy in Japanese male subjects. Dig Dis Sci 2007;52:1691-7
   PubMed Web of Science ®Google Scholar
• Peng S, Kuang Z, Sheng C, Association of MicroRNA- 196a-2 Gene Polymorphism with Gastric Cancer Risk in a Chinese Population. Dig Dis Sci 2010;55:2288-93
   PubMed Web of Science ®Google Scholar
• Takei Y, Takigahira M, Mihara K, The metastasis- associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer. Cancer Res 2011;71:1442-53
   PubMed Web of Science ®Google Scholar
• Lang N, Liu M, Tang Ql, Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines. Chin J Cancer 2010;29:603-10
   PubMedGoogle Scholar
• Tsujiura M, Ichikawa D, Komatsu S, Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010;102:1174-9
   PubMed Web of Science ®Google Scholar
• Wu WK, Lee CW, Cho CH, MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 2010;29:5761-71
   PubMed Web of Science ®Google Scholar
• Chin LJ, Ratner E, Leng S, A SNP in a let-7 microRNA complementary site in the KRAS 30 untranslated region increases non-small cell lung cancer risk. Cancer Res 2008;68:8535-40
   PubMed Web of Science ®Google Scholar
• Wiggins JF, Ruffino L, Kelnar K, Development of a lung cancer therapeutic based on the tumor suppress or microRNA-34. Cancer Res 2010;70:5923-30
   PubMed Web of Science ®Google Scholar
• Cho WC, Chow AS, Au JS. miR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol 2011;8:125-31
   PubMed Web of Science ®Google Scholar
• Hu Z, Chen X, Zhao Y, Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010;28:1721-6
   PubMed Web of Science ®Google Scholar
• Yu SL, Chen HY, Chang GC, MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2010;13:48-57
   Web of Science ®Google Scholar
• Gao W, Lu X, Liu L, MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer. Cancer Biol Ther 2012;13(6):330-340
   PubMedGoogle Scholar
• Akao Y, Nakagawa Y, Naoe T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 2006;29:903-6
   PubMed Web of Science ®Google Scholar
• Feng YH, Wu CL, Tsao CJ, Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: correlation with the clinical stage of the disease. Cancer Biol Ther 2011;11:111-21
   PubMed Web of Science ®Google Scholar
• Wang P, Zou F, Zhang X, microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 2009;69:8157-65
   PubMed Web of Science ®Google Scholar
• Gregersen LH, Jacobsen AB, Frankel LB, MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One 2010;5:e8836
   PubMedGoogle Scholar
• Chintharlapalli S, Papineni S, Abdelrahim M, Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells. Int J Cancer 2009;125:1965-74
   PubMed Web of Science ®Google Scholar
• Guo LM, Pu Y, Han Z, MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J 2009;276:5537-46
   PubMed Web of Science ®Google Scholar
• Li J, Liang SH, Lu X. Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis. Zhonghua Fu Chan Ke Za Zhi 2010;45:787-92
   PubMedGoogle Scholar
• Ye G, Fu G, Cui S, MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance. J Cell Sci 2011;124:359-68
   PubMed Web of Science ®Google Scholar
• Yang N, Kaur S, Volinia S, MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 2008;68:10307-14
   PubMed Web of Science ®Google Scholar
• Lopotova T, Zackova M, Klamova H, MicroRNA-451 in chronic myeloid leukemia: miR-451–BCR-ABL regulatory loop? Leuk Res 2011;35(7):974-7
   PubMed Web of Science ®Google Scholar
• Scholl V, Hassan R, Zalcberg IR. miRNA-451: a putative predictor marker of Imatinib therapy response in chronic myeloid leukemia. Leuk Res 2012;36:119-21
   PubMed Web of Science ®Google Scholar
• Faber J, Gregory RI, Armstrong SA. Linking miRNA regulation to BCR-ABL expression: the next dimension. Cancer Cell 2008;13(6):467-9
   PubMed Web of Science ®Google Scholar
• Thai TH, Calado DP, Casola S, Regulation of the germinal center response by microRNA-155. Science 2007;316(5824):604-8
   PubMed Web of Science ®Google Scholar
• Frenquelli M, Muzio M, Scielzo C, MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27. Blood 2010;115:3949e59
   Google Scholar
• Gordanpour A, Stanimirovic A, Nam RK, miR-221 Is Down-regulated in TMPRSS2:ERG fusion-positive prostate cancer. Anticancer Res 2011;31:403-10
   PubMed Web of Science ®Google Scholar
• Wei JJ, Wu X, Peng Y, Regulation of HMGA1 expression by MicroRNA-296 affects prostate cancer growth and invasion. Clin Cancer Res 2011;17:1297-05
   PubMed Web of Science ®Google Scholar
• Kasinski AL, Slack FJ. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011;11:849-64
   PubMed Web of Science ®Google Scholar
• Nana-Sinkam SP, Croce CM. MicroRNAs as therapeutic targets in cancer. Transl Res 2011;157:216-25
   PubMed Web of Science ®Google Scholar
• Gravgaard KH, Lyng MB, Laenkholm AV, The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer. Breast Cancer Res Treat 2012; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Tanic M, Zajac M, Gomez-Lopez G, Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFkappaB pathway. Breast Cancer Res Treat 2011; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Zhong XY, Yu JH, Zhang WG, MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. Gene 2012;493:44-51
   PubMed Web of Science ®Google Scholar
• Kastl L, Brown I, Schofield AC. miRNA-34a is associated with docetaxel resistance in human breast cancer cells. Breast Cancer Res Treat 2012;131:445-54
   PubMed Web of Science ®Google Scholar
• Oliveras-Ferraros C, Cufi S, Vazquez-Martin A, Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: induction of the tumor suppressor miRNA let-7a and suppression of the TGFbeta-induced oncomiR miRNA-181a. Cell Cycle 2011;10(7):1144-51
   PubMed Web of Science ®Google Scholar
• Hou Z, Xie L, Yu L, MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis, Med Oncol. 2011;10:9862-7
   Google Scholar
• Jin Z, Selaru FM, Cheng Y, MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene 2011;30:1577-85
   PubMed Web of Science ®Google Scholar
• Gao C, Zhang Z, Liu W, Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 2010;116:41-9
   PubMed Web of Science ®Google Scholar
• Kim CH, Kim HK, Rettig RL, miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genomics 2011;4(1):79
   PubMedGoogle Scholar
• Li X, Zhang Y, Zhang H, miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 2011;9(7):824-33
   PubMed Web of Science ®Google Scholar
• Ebi H, Sato T, Sugito N, Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers. Oncogene 2009;28:3371-9
   PubMed Web of Science ®Google Scholar
• Wang XC, Tian LL, Jiang XY, The expression and function of miRNA-451 in non-small cell lung cancer. Cancer Lett 2011;311(2):203-9
   PubMed Web of Science ®Google Scholar
• Leidinger P, Keller A, Borries A, Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer 2011;74(1):41-7
   PubMed Web of Science ®Google Scholar
• Gao JS, Zhang Y, Tang X, The evi1, microRNA-143, K-Ras axis in colon cancer. FEBS Lett 2011;585:693-9
   PubMed Web of Science ®Google Scholar
• Oberg AL, French AJ, Sarver AL, miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS One 2011;6(6):e20465
   PubMed Web of Science ®Google Scholar
• Wang XY, Wu MH, Liu F, Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells. Mol Cell Biochem 2010;345(1-2):283-90
   PubMed Web of Science ®Google Scholar
• Iorio MV, Visone R, Di Leva G, MicroRNA signatures in human ovarian cancer. Cancer Res 2007;67:8699-07
   PubMed Web of Science ®Google Scholar
• Cancer Cell13, June 2008 ª2008 Elsevier, Inc
   Google Scholar
• de Oliveira JC, Scrideli CA, Brassesco MS, Differential MiRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features Leuk Res. 2012;36(3):293-8
   Google Scholar
• Zhang B, Pan X, Cobb GP, microRNAs as oncogenes and tumor suppressors. Dev Biol 2007;302:1-12
   PubMed Web of Science ®Google Scholar
• Pallasch CP, Patz M, Park YJ, miRNA deregulation by epigenetic silencing disrupts suppression of the PLAG1 oncogene in chronic lymphocytic leukemia. Blood 2009;114(15):3255-64
   PubMed Web of Science ®Google Scholar
• Song YX, Yue ZY, Wang ZN, MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer 2011;10:1
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Shi Y, MicroRNA-107, an Oncogene MicroRNA that regulates tumor invasion and metastasis by targeting DICER1 in gastric cancer: miR-107 promotes gastric cancer invasion and metastasis. J Cell Mol Med 2011;10:1887-95
   Google Scholar
• Liu X, Sempere LF, Ouyang H, MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 2009;120:1298-09
   Web of Science ®Google Scholar
• Zhang JG, Guo JF, Liu DL, MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. J Thorac Oncol 2011;6:671-8
   PubMed Web of Science ®Google Scholar
• Zhang JG, Wang JJ, Zhao F, MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 2010;411:846-52
   PubMed Web of Science ®Google Scholar
• Lin Z, Flemington EK. miRNAs in the pathogenesis of oncogenic human viruses. Cancer Lett 2011;305(2):186-99
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xu H, Yao Y, Critical role of the virus-encoded MicroRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS Pathog 2011;7(2):e1001305
   PubMed Web of Science ®Google Scholar
• Feederle R, Linnstaedt SD, Bannert H, A Viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog 2011;7(2):e1001294
   PubMedGoogle Scholar